by PEPID Newsroom | Nov 9, 2018 | Alerts
The FDA announced emergency use authorization for a rapid, single-use test to detect the Ebola Virus (Zaire ebolavirus). The test, called the DPP Ebola Antigen System (Chembio Diagnostic Systems Inc), is novel for using a portable battery reader for accurate...
by PEPID Newsroom | Nov 9, 2018 | Alerts
A French study finds an association between a higher frequency of organic food consumption and a reduced risk of cancer. The study findings still need to be confirmed. In this population-based cohort study of 68,947 French adults, high organic food scores were...
by PEPID Newsroom | Nov 7, 2018 | Alerts
A cohort study by the United Kingdom Clinical Research Datalink associated the use of ACEIs with an increased risk of lung cancer. The association elevated among people using ACE Inhibitors for more than five years. The study consisted of 992,061 patients treated with...
by PEPID Newsroom | Nov 2, 2018 | Alerts
Yesterday, November 1st, the federal Centers for Medicare & Medicaid Services (CMS) published their final rule for the Physician Fee Schedule for CY 2019, and Quality Payment Program (QPP)—regarding the Patients Over Paperwork Initiative, E&M requirements,...
by PEPID Newsroom | Nov 1, 2018 | Alerts
23andMe is the first direct-to-consumer (DTC) genetic test to be permitted by the FDA to market their pharmacogenomic reports providing information regarding genetic variants that may be associated with a patient’s ability to metabolize some medications to help inform...
by PEPID Newsroom | Oct 31, 2018 | Alerts
Yesterday the U.S. Food and Drug Administration approved Xofluza (balorxavir marhboxil), a new influenza treatment for acute uncomplicated influenza in people age 12 and older who have been symptomatic for no more than 2 days. This new drug, developed by Genentech,...
by PEPID Newsroom | Oct 22, 2018 | Alerts
The CDC is baffled by the cause of polio-like disease, Acute Flaccid Myelitis (AFM), affecting children in the United States. A reoccurring outbreak of AFM has been affecting Americans 21 and under since 2014. The CDC has recorded spikes in cases of Acute Flaccid...
by PEPID Newsroom | Oct 22, 2018 | Alerts
Toxic dinoflagellates algal blooms known as “red tides” are spreading across the Florida coastline, killing thousands of marine animals, and causing respiratory and gastrointestinal distress in residents. People in effected areas are warned not to swim in the water,...
by PEPID Newsroom | Oct 2, 2018 | Alerts
The FDA approved cemiplimab-rwlc (Libtayo) for treatment of locally advanced, or metastatic, cutaneous squamous cell carcinoma (CSCC). This is the first drug treatment approved for advanced CSCC, the second most common cancer in the U.S. Please see the FDA website for...
by PEPID Newsroom | Aug 17, 2018 | Alerts
The FDA has approved the first generic version of Mylan’s EpiPEN and EpiPen Jr (epinephrine) auto injector used to treat emergency allergic reactions, such as the life-threatening anaphylaxis. The generic epinephrine auto-injector has been green flagged to market in...
by PEPID Newsroom | Aug 16, 2018 | Alerts
The U.S. FDA approved the first of its kind targeted RNA-based therapy Onpattro (patisiran) to treat peripheral nerve disease (polyneuropathy) caused from hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients. This is the first FDA approved treatment...
by PEPID Newsroom | Jul 12, 2018 | Alerts
Tecovirimat (TPOXX) is the first FDA approved drug treatment of smallpox. In 1980, WHO declared that smallpox was eradicated; however, tecovirimat was developed as a counter to the possible use of smallpox as a bio-weapon. It is the first product awarded a Material...
by PEPID Newsroom | Jul 2, 2018 | Alerts
Another mosquito-borne virus has been confirmed to infect humans, after a report published in June from the peer-reviewed medical journal Clinical Infectious Diseases. Keystone has been known to infect animals since its discovery in Tampa-Bay area in 1964 but has...
by PEPID Newsroom | Jun 13, 2018 | Alerts
The Journal of the American Medical Association published a study with evidence to reveal adults taking concurrent medications with the adverse side effect of causing depression have a heightened risk of depressive symptoms. The researchers assessed the prescribed...
by PEPID Newsroom | Jun 8, 2018 | Alerts
The American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists’ Committees on Pain Medicine and Standards and Practice Parameter have determined a consensus guideline for the...
